← Back
$HCAT All transactions

Health Catalyst, Inc.

A

$ Value

$0

Shares

930,000

Price

$0

Filed

Feb 27

Insider

Name

Albert Benjamin

Title

CEO

CIK

0002086403

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-25

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,507,870

Footnotes

Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 16.67% of the RSUs will vest on March 1st, 2026, and, thereafter, the remaining 83.33% of the RSUs will vest in 10 equal quarterly installments. | Represents an award of 38,833 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. | Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Filing Info

Accession No.

0002086403-26-000001

Form Type

4

Issuer CIK

0001636422

Albert Benjamin's History

Date Ticker Type Value
2026-03-10 HCAT F $130K
2026-03-02 HCAT F $8K
2026-02-26 HCAT F $23K
2026-02-25 HCAT A $0
2026-02-25 HCAT A $0
2025-09-24 HCAT A $0

Other Insiders at HCAT (90d)

Insider Bought Sold Last
Llewelyn Linda
Chief People Officer
2026-03-02
Gallagher Duncan 2026-02-17
Larson-Green Julie 2026-03-01
Alger Jason
Chief Financial Officer
2026-03-02
Landry Benjamin
General Counsel
2026-03-02
Albert Benjamin
CEO
2026-03-10